ReviewActa medica academica2022
Tumor-Type Agnostic, Targeted Therapies: BRAF Inhibitors Join the Group.
Semir Vranic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled itcites it
ReviewActa medica academica2022
Semir Vranic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.